Physician profile
Philip Andrew Woodworth
NPI 1235197492
$1,347,101.24
in general payments reported to CMS, 2019-2025
30 companies · $299K in 2025
The $299K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253K · 2020: $98K · 2021: $130K · 2022: $174K · 2023: $172K · 2024: $222K · 2025: $299K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $343K · Honoraria: $234K · Travel and Lodging: $71K · Food and Beverage: $23K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Education: $2,000 · Gift: $33.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $343,271.26 |
| Honoraria | $234,422.00 |
| Travel and Lodging | $71,228.74 |
| Food and Beverage | $23,089.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,192.00 |
| Education | $2,000.00 |
| Gift | $33.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $449,227.07 | 2019-2025 | Linx Reflux Management System |
| Davol INC. | $286,775.51 | 2020-2025 | Phasix Mesh, Arista Ah Flexitip, Arista |
| Ethicon US, LLC | $257,167.52 | 2019-2025 | Linx Reflux Management System, Linx Reflux Management System |
| Stryker Corporation | $152,186.99 | 2019-2025 | 1688, 1788, Spy-Phi System |
| Tela Bio, INC. | $88,070.69 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Intuitive Surgical, INC. | $58,308.52 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Conmed Corporation | $41,787.54 | 2022-2025 | Airseal, Visiclear, Conmed Specimen Retrieval |
| Lucid Diagnostics INC. | $6,625.98 | 2022-2024 | |
| W. L. Gore & Associates, INC. | $2,026.90 | 2022-2025 | Gore Bio-A Tissue Reinforcement, Product In Development, Gore Enform Preperitoneal Biomaterial |
| Becton, Dickinson and Company | $1,504.20 | 2023-2025 | Phasix Mesh, Arista Ah Flexitip, Channel Drain |
| Medtronic, INC. | $1,151.87 | 2021-2024 | Endoflip, Gi Genius, Endo Clip III |
| Enterra Medical, INC. | $469.00 | 2023 | |
| Endogastric Solutions, INC | $465.37 | 2022 | |
| Ambu INC. | $275.87 | 2024-2025 | |
| Pinnacle Biologics, INC | $269.55 | 2025 | Photofrin |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $217.60 | 2023-2024 | |
| Acera Surgical, INC. | $131.46 | 2021 | |
| Virtual Incision Corporation | $85.00 | 2024 | Mira |
| Anx Robotica Corp | $75.80 | 2022 | |
| Paratek Pharmaceuticals, INC. | $38.07 | 2019-2020 | |
| Ethicon INC. | $37.77 | 2019 | |
| Organogenesis INC. | $34.73 | 2023 | Puraply |
| Apollo Endosurgery US INC | $33.36 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $28.11 | 2025 | Dupixent |
| Dilon Technologies, INC. | $26.05 | 2024 | Hemoblast Bellows |
| Csl Behring | $23.46 | 2019 | |
| Ethicon Endo-Surgery INC. | $16.82 | 2023 | Linx Reflux Management System |
| Integra Lifesciences Corporation | $14.73 | 2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Acell, INC. | $12.89 | 2019 | |
| Endo Pharmaceuticals INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Woodworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.